Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Minarini

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
European Journal of Medicinal Chemistry|September 21, 2023
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic propertiesFilippo Basagni, Jose A Ortega, Sine M Bertozzi, et al.
Journal of Medicinal Chemistry|July 9, 2008
Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rushMichela Rosini, Elena Simoni, Manuela Bartolini, et al.
Journal of Medicinal Chemistry|August 8, 2025
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based InhibitorsGiambattista Marotta, Francesca Massenzio, Jose Ortega, et al.
Journal of Medicinal Chemistry|September 14, 2007
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's diseaseMaria Laura Bolognesi, Rita Banzi, Manuela Bartolini, et al.
Journal of Chemical Information and Modeling|August 10, 2022
Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3-D QSAR StudiesRino Ragno, Anna Minarini, Eleonora Proia, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 3, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastomaGuendalina Zuccari, Andrea Milelli, Fabio Pastorino, et al.
Journal of Medicinal Chemistry|October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over βJose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
European Journal of Medicinal Chemistry|July 24, 2012
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agentsAndrea Milelli, Vincenzo Tumiatti, Marialuisa Micco, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
European Journal of Medicinal Chemistry|September 21, 2023
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic propertiesFilippo Basagni, Jose A Ortega, Sine M Bertozzi, et al.
Journal of Medicinal Chemistry|July 9, 2008
Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rushMichela Rosini, Elena Simoni, Manuela Bartolini, et al.
Journal of Medicinal Chemistry|August 8, 2025
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based InhibitorsGiambattista Marotta, Francesca Massenzio, Jose Ortega, et al.
Journal of Medicinal Chemistry|September 14, 2007
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's diseaseMaria Laura Bolognesi, Rita Banzi, Manuela Bartolini, et al.
Journal of Chemical Information and Modeling|August 10, 2022
Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3-D QSAR StudiesRino Ragno, Anna Minarini, Eleonora Proia, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 3, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastomaGuendalina Zuccari, Andrea Milelli, Fabio Pastorino, et al.
Journal of Medicinal Chemistry|October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over βJose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
European Journal of Medicinal Chemistry|July 24, 2012
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agentsAndrea Milelli, Vincenzo Tumiatti, Marialuisa Micco, et al.
Pageof 8